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Several studies have aimed to compare the early and late survival rates and the 
related factors in patients who undergo coronary artery bypass grafting (CABG). 
Among such factors are age, gender, arrhythmia, stroke, serum procalcitonin level, 
number and type of grafts, diabetes mellitus, chronic kidney disease, chronic 
obstructive pulmonary disease (COPD), addiction, ejection fraction, transfu-
sion of blood products, and the kind of technique (off-pump versus on-pump). 
Controversies surround early and late survival and some of the associated factors in 
patients undergoing CABG. Therefore, it appears vital to compare the early and late 
survival chances and the related factors after CABG.
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1. Introduction
CABG continues to be the most common procedure in adult cardiac surgery 
for coronary artery disease [1]. CABG improves survival, particularly in complex 
diabetic patients, those above 65 years of age, patients with left main stem or triple-
vessel disease, and those who have an impairment in the left ventricular function [2].
Many studies have attempted to compare the early and late survival rates and 
the relevant factors in patients who undergo CABG. A 20-year follow-up investiga-
tion of patients undergoing CABG reported lower survival rates as related to the 
female gender, age, hypertension, previous CABG, angina class, number of vessels 
diseased, heavyweight, and ejection fraction (EF) [3]. Another study shows that 
late survival is associated with increased weight, history of myocardial infarction, 
smoking, diabetes, and application of vein grafts merely in CABG patients [4].
In light of the current controversy over early and late survival rates and some 
of the related factors in patients undergoing CABG, it seems critically important to 
compare the early and late survival chances and associated factors after CABG.
1.1 Gender
Most studies report that women hold a higher risk for morbidity and mortality 
after CABG procedures than their male counterparts do [5, 6]. Abramov’s study 
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demonstrated that there is a greater prevalence of most risk factors in women 
(including old age, urgent operation, prior PTCA, Canadian Cardiovascular Society 
angina class 3–4, congestive heart failure, hypertension, diabetes mellitus, periph-
eral vascular disease, and smaller body surface area). Men have a higher prevalence 
of left ventricular EF of <35%, triple-vessel disease, and history of smoking. 
Moreover, Abramov’s study found that internal mammary artery grafts and mul-
tiple arterial grafts were not used as frequently in women as in men [5]. It should 
be highlighted that a critical difference between men and women is the later onset 
of coronary artery disease in women. By inference, after age is controlled, female 
patients undergoing surgery may have a shorter duration of coronary artery disease, 
which would be associated with longer life [5].
1.2 Age
Demographic changes over the last decades have resulted in a different patient 
population for surgeons, including cardiac surgeons. It is now typical of elderly 
patients to have several, relatively severe comorbidities such as hypertension, pul-
monary diseases, diabetes, obesity, renal insufficiency, as well as peripheral arterial 
disease (PAD) [7].
Alongside this, Naughton compared the early and late predictors of mortality 
after on-pump CABG in an elderly and a younger population, showing that mor-
tality in elderly patients improved substantially, although it remained more than 
twice that of younger patients. The difference in contributors to early and 1-year 
mortality implies the need for effectual short- and long-term strategies, especially 
in controlling chronic diseases such as heart and renal failure [8].
Coronary artery revascularization via CABG surgery or percutaneous coronary 
intervention in 80-year-old patients or older can have satisfactory in-hospital and 
2-year clinical outcomes. Nevertheless, recovery may be prolonged in up to 20% of 
patients, and they may not be immediately able to leave the hospital [9].
In Nicolini’s study [10], patients younger than 60 years undergoing CABG 
showed a lower risk of undesirable outcomes than older patients. Patients younger 
than 60 have a different clinical pattern of coronary artery disease (CAD) pre-
sentation as compared to more elderly patients. Especially speaking, the factors 
of obesity, male gender, the history of myocardial infarction, the history of PCI, 
and the presence of depressed left ventricular function, have been found to be 
highly commonplace among patients younger than 60. Focused attention should be 
directed to these issues if one aims to design and improve preventive strategies than 
can alleviate the effect of specific cardiovascular risk factors for younger patients, 
including lifestyle, diet, and weight control. More research with longer follow-up 
periods should be performed to investigate the efficacy and durability of myocar-
dial revascularization in younger patients in need of CABG [10].
1.3 Biomarkers
According to Petäjä’s meta-analysis, postoperative CK-MB release is linked with 
survival up to 40 months after surgery. Troponin levels can assumedly be better 
predictors of mortality than CK-MB due to their specificity to the myocardium [11].
Also, high levels of postoperative serum procalcitonin have been demonstrated 
to correlate with infection, mortality, and other severe post-cardiac surgery com-
plications [12]. Dörge et al. revealed that survival rates in the first 24 h after the 
operation are lower in patients with high levels of serum PCT [13]. Fritz et al. [14] 
also reported that a PCT level greater than 2.5 ng l−1 could be predictive of mortality 
within the first 28 days after CABG surgery [14].
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1.4 Type of grafts
Completeness of revascularization is contingent upon the number of grafts 
required, the type of graft, and the number of grafts performed [15]. Saphenous 
vein grafts (SVG) are the most frequently employed conduits from among arte-
rial and venous conduits for CABG surgery. It is because they are characterized 
by superficial access site and reduced risk for bleeding compared with arterial 
conduits. Endoscopic SVG harvest was reported to have short-term graft patency 
similar to open SVG harvest, although there are concerns for a significantly reduced 
long-term graft patency at 12 months and beyond. Given the potential implications 
of endoscopic SVG harvest for deteriorated long-term outcomes in patients under-
going CABG, its role has received much controversy in the literature, although it is 
generally considered non-subsidiary to open harvest [1].
Amouzeshi’s study showed that EVH is a safe and minimally invasive technique 
for vein harvesting and that it can decrease the harvest time and postoperative pain. 
Moreover, the efficiency of EVH and OVH is similar. Nevertheless, further research 
is needed to probe into its cosmetic outcomes, cost-efficiency, and hospital costs; it is 
even more essential to study the long-term graft patency of the EVH technique [16].
The systematic review and meta-analysis conducted by Kodia on 18,131 patients 
undergoing CABG showed greater patency via open SVG harvest than endoscopic 
SVG harvest after a follow-up of around 2.5 years. Patients with open SVG harvest 
showed higher rates of early wound complications and postoperative 30-day mor-
tality, which, importantly, did not mean differences in overall mortality [1].
Finally, Grau’s study indicated that bilateral internal mammary artery had better 
outcomes than single internal mammary artery [17].
A meta-analysis incorporating 27 studies and over 79,000 patients revealed 
a higher survival rate among patients who received bilateral internal mammary 
artery (BIMA) as compared with those who underwent left internal mammary 
artery for CABG surgery. While it is imperative to tailor the surgery to each patient, 
no one can disregard the advantage and gain from this operative strategy. Moreover, 
given the reduced rates of short-term morbidity (i.e., deep sternal wound infec-
tion) through better operative techniques, BIMA bypass grafting can be a first-line 
alternative for patients receiving revascularization [18].
1.5 Stroke
Stroke is a primary cause of morbidity and mortality following CABG. It continues 
to be one of the most disabling and damaging complications of CABG, which carries 
significant clinical and economic implications for both patients and the healthcare 
system [19, 20]. Moreover, it is a potentially preventable complication of CABG [20].
The results from Tarakji’s study on patients undergoing CABG at a single center 
during a 30-year period showed that the incidence of stroke reduced despite an 
increasing patient risk profile and that over half of strokes occurred postoperatively 
rather than intraoperatively. Clinical presentation and surgical technique were 
specific to intraoperative stroke, but age and arteriosclerotic burden were associated 
with both intraoperative and postoperative strokes [20].
In Mao’s study, seven variables (including advanced age, prior carotid artery ste-
nosis, history of cerebrovascular disease/stroke, prior peripheral vascular disease, 
prior unstable angina, prolonged cardiopulmonary bypass time, and postoperative 
atrial fibrillation), representing high atherosclerotic burden, were found related to 
perioperative stroke events [19].
In the course of a surgical procedure, there are three different mechanisms 
that may trigger postoperative strokes: (1) embolic events, (2) defects in brain 
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perfusion, and (3) an inflammatory response, which can, in cases, intensify the 
other mechanisms [21].
Postoperative neurological complications, particularly those with a deficit, 
are especially destructive. Mainly, they are the outcome of macroparticle emboli 
associated with aortic atherosclerosis. It stands as a paradox that off-pump surgery 
has provided for a better recognition of the numerous pathophysiological processes, 
which might induce postoperative complications, most notably the neurological 
difficulties. It is now possible to measure the benefits that have become available 
by modified surgical practices and cardiopulmonary bypass (CPB). Modification 
of current cardiological therapies, with an increased use of antiplatelet agents and 
preoperative interventional procedures, may alter the surgical scene. As a result, 
many pathophysiological aspects may need further research [21].
1.6 Arrhythmia
Atrial fibrillation (AF) is one of the most common complications following 
cardiac surgery. It may happen in ~20–35% of cases after CABG surgery and in over 
50% of patients upon valve surgery. AF after cardiac surgery is a primary cause of 
morbidity and mortality in patients [22].
In case preoperative atrial fibrillation is left uncorrected in patients undergoing 
CABG, it has been demonstrated that greater late cardiac morbidity and mortality 
as well as poorer long-term survival will follow. Thus, atrial fibrillation surgery 
should be considered at the time of CABG. It has yet to be determined whether the 
ablation of atrial fibrillation at the time of CABG can enhance prognosis, yet the 
present data support the idea of considering concurrent AF surgery [23].
Also, prior AF in patients who undergo CABG has been recognized as an incre-
mental risk factor for time-related mortality. Even after being adjusted for risk 
factors of stroke, the patients with AF have a more substantial stroke risk of 2.6–4.5 
times. The reason for the late increased mortality in patients with AF is not well 
known. Unquestionably, the higher chance of stroke and bleeding is explained by 
some of the difference; however, several studies also indicate that chronic tachycar-
dia is linked with late mortality [24].
1.7 Diabetes mellitus (DM)
Patients suffering from DM bear a higher chance of adverse outcomes after 
CABG [25]. Thourani’s study showed that DM has both worse in-hospital and long-
term outcomes after CABG. The increased risk in DM patients can only partially 
be accounted for by demographic characteristics. Moreover, this study showed that 
diabetic patients were older and had more extensive coronary artery disease, a lower 
preoperative EF, a higher incidence of hypertension, prior myocardial infarction, 
heart failure, and class III–IV angina at the time of presentation [26].
In Zoltan Szabo’s study, diabetic patients could undergo CABG in case they had 
an acceptable mortality risk, which was only slightly different from that found in 
nondiabetic patients. Cardiac grounds for early mortality were predominant in both 
diabetic and nondiabetic patients. However, the neurologic injury was evidence for 
a relatively higher proportion of early deaths in diabetic patients. Besides, midterm 
survival was noticeably compromised, especially in diabetic patients treated with 
insulin [27].
Calafiore’s study showed that diabetes is an independent risk factor only for 
early cardiac mortality. Long-term survival in those who live the first 30 days does 
not differ significantly in diabetic and nondiabetic patients. In fact, the rates are 
very close [28].
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A large 11-year-long nationwide cohort of patients undergoing a first isolated 
CABG in Sweden showed that the risk of death after CABG was double in patients 
with type 1 DM (T1DM) than patients without DM. Moreover, the cohort found 
that patients with type 2 diabetes mellitus (T2DM) had almost a similar risk of 
death as patients without diabetes. According to the cohort, patients with T1DM 
grow a high risk of adverse outcomes after CABG and should be intently followed 
up. Moreover, all possible measures need to be taken to reduce the risks of mortality 
or recurrent cardiovascular events in them [25].
Therefore, diabetic patients form a significant portion of the population under-
going surgical coronary revascularization.
1.8 Chronic kidney disease (CKD)
Creatinine levels are of a crucial role in on-pump coronary bypass grafting mor-
tality. A worse prognosis may result from the combination of some risk factors and 
higher admission creatinine values. Moreover, lower admission creatinine values 
have been linked with a protective impact, even among elderly patients and those 
with a high cardiopulmonary bypass time [29].
Miceli’s study indicates that occult renal dysfunction, i.e., normal creatinine 
level with impaired renal function, is connected with higher mortality and post-
operative morbidity in CABG patients. A precise assessment of renal function, by 
estimating creatinine clearance and serum creatinine, can help detect patients at 
higher risks and categorize risks more accurately so that therapeutic strategies can 
be better optimized for these patients [30].
1.9 Chronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease is associated with prolonged mechanical 
ventilation, prolonged length of stay, and postoperative complications such as pneu-
monia. It is similarly a principal predictor of long-term survival after CABG [31].
In one meta-analysis study (2019), COPD was not predictive of increased risks 
of postoperative mortality after CABG. Nevertheless, the study revealed that 
patients with COPD developed higher chances of developing postoperative mor-
bidities, especially pneumonia, respiratory failure, renal failure, stroke, and wound 
infection. Therefore, when a patient with COPD requires CABG, caution should be 
taken in light of the higher risk for developing postoperative complications as with 
the respiratory system and others. High-quality RCTs are needed to confirm these 
results, however [32].
In Efird’s study [31], COPD and prolonged length of stay were two of the several 
contributors to long-term postoperative mortality in CABG patients. In this regard, 
to reduce length of stay after CABG, it might be necessary to take aggressive treat-
ment strategies with an aim for early weaning off of mechanical ventilation and 
prevention of reintubation among COPD patients. Our findings also have important 
implications for the long-term management of these patients and strategies for 
managing costs as the patient lives on [31].
1.10 Type of technique (off-pump versus on-pump)
Many studies have investigated the outcomes of off-pump and on-pump 
CABG. Nevertheless, their results are contradictory, and the advantages and dis-
advantages of the two methods are not clearly explained [33, 34]. Some studies 
have argued for the superior outcomes of off-pump CABG, primarily as concerned 
with short- and long-term mortality rates and complications. However, some other 
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studies have reported no significant differences between the two techniques [35, 36]. 
As an example, in a meta-analysis of mid- and long-term outcomes (2014), off-pump 
and on-pump CABG conferred similar midterm survival rates. On-pump CABG, 
however, was connected with better chances of long-term survival [36].
According to the results of Amouzeshi’s study, the outcomes (e.g., death, myo-
cardial infarction, rehospitalization, and normal physical activity) were not signifi-
cantly different between off-pump and on-pump CABG in patients who underwent 
primary isolated non-emergent CABG during a 6-year follow-up phase [15].
In Raja’s study, off-pump CABG versus on-pump CABG is correlated with 
comparable short-, mid-, and long-term mortality, similar organ protection, and 
fewer distal anastomoses. The available evidence cannot, nonetheless, substantiate 
all concerns about the safety and efficacy of off-pump CABG [37].
1.11 Addiction
Opioids are generally used as anesthetic agents. Long-term application of 
opioids can lead to analgesic tolerance via an unclear mechanism. Thus, addicted 
patients may require higher opioid doses [38].
Opiate addiction in CABG patients is of relatively high prevalence. Some studies 
indicate that drug addiction increases postoperative bleeding and risks of readmis-
sion in patients undergoing CABG. Besides, drug addiction together with pain sup-
pression and changes in the endocrine system and cytokines can alter the process of 
wound healing in patients undergoing surgery [39].
Nemati’s study showed that inhalational opium addiction is linked with higher 
bleeding after CABG. Given the overwhelming number of individuals with opium 
addiction who might need CABG in countries where opium addiction is wide-
spread, cardiac surgeons need to consider these patients as being at high risk for 
major complications after surgery [40].
Given the fairly high prevalence of opium abuse among patients undergoing 
cardiac surgery and its potential prediction of AF after cardiac surgery, cardiac 
surgeons need to take better preventive measures when planning surgery for opium 
addict patients [22].
1.12 Ejection fraction
In patients undergoing CABG, the grade of left ventricular EF impairment, 
which reflects a decreased amount of contracting myocardium, stands as a recog-
nized risk factor for poor short-term and long-term prognoses [41].
Patients with low EF are at higher risks of ventricular arrhythmia, sudden death, 
and deteriorating heart failure because of recurrent ischemia. In patients with 
low EF, CABG is demonstrated to be superior to medical therapy alone, leading to 
significant clinical enhancement and improved long-term survival [42].
Pieri’s study [43] showed that moderate-to-severe left ventricular dysfunction is 
a typical finding in the general population undergoing cardiac surgery. Those with 
reduced low preoperative left ventricular EF undergoing cardiac surgery carry a 
high risk of postoperative complications as well as a higher mortality rate. However, 
the operation can be performed with a comparatively low mortality rate [43].
Haxhibeqiri-Karabdic’s study [44] showed that in patients with left ventricular 
dysfunction, CABG could be performed safely with improvement in life quality and 
left ventricular EF.
Developments in preoperative management, enhancements in surgical 
techniques, application of off-pump CABG, advances in cardiac anesthesia, and 
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improvement in intensive postoperative care have led to a decreased mortality rate 
in patients with low EF operated by off-pump CABG [42].
Inamdar’s study [42] revealed that in patients with coronary artery disease and 
low EF, off-pump CABG could be performed as a relatively safe procedure. It results 
in good midterm survival, improved left ventricular function, and enhanced overall 
life quality [42].
Amouzeshi’s study [45] showed that even though an EF below 30% is an 
independent risk factor of mortality, proper care could minimize mortality after 
CABG. Besides, the study suggested inquiring into the impact of length of time 
after surgery and variables such as postoperative hospital care, surgical technique, 
the surgeon himself, and patient self-care training in more hospitals. It is neces-
sary to note that the mortality rate of 10% in patients with EF below 30 and 5% in 
patients with EF above 30% in this investigation is quite satisfactory according to 
global standards [34].
Moreover, it is critical to have a careful preoperative selection and operative 
management, including optimal strategies of myocardial preservation for patients 
with low EF undergoing cardiac surgery [45].
1.13 Transfusion of blood products
Transfusion of blood products in patients undergoing CABG is linked with 
higher mortality and morbidity [46]. A few studies have revealed an association 
between blood transfusion and lower long-term survival after CABG [47].
Van Straten’s study revealed that the number of transfused RBC is an inde-
pendent predictor of early but not late mortality after CABG. Compared to the 
expected survival, receiving no RBC improves the patient’s long-term survival, 
whereas receiving three or more units of RBC decreases the patient’s survival 
significantly [46].
Mikkola’s study showed that transfusion of any blood product is connected with 
significantly increased risks of all-cause and cardiac mortality after CABG. Such 
risks seem to be confined to the early postoperative period and decline later on. The 
perioperative use of fresh frozen plasma or Octaplas, from among blood products, 
appears to be the primary predictor of mortality [47].
These findings suggest that patient blood management is of extreme impor-
tance in enhancing postoperative outcomes, even in low-risk patients undergoing 
CABG [48].
2. Conclusions
In addition to cardiac-related and operation-related factors, patient-related 
contributors including senior age, comorbidity, female gender, and clinical pre-
operative situation can affect the clinical outcome of patients after CABG. This 
surgical procedure is a multidimensional phenomenon. In this regard, cardiac 
rehabilitation/secondary prevention programs can play a critical role in enhancing 
the process of care and outcome of this growing high-risk group of patients.
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